Page last updated: 2024-11-01

niclosamide and Leukemia

niclosamide has been researched along with Leukemia in 1 studies

Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, AM1
Ku, HH1
Liang, YC1
Chen, YC1
Hwu, YM1
Yeh, TS1

Other Studies

1 other study available for niclosamide and Leukemia

ArticleYear
The autonomous notch signal pathway is activated by baicalin and baicalein but is suppressed by niclosamide in K562 cells.
    Journal of cellular biochemistry, 2009, Mar-01, Volume: 106, Issue:4

    Topics: Antiparasitic Agents; Cell Differentiation; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Fla

2009